TC Jenkins, EM Gardner, MW Thrun, DL … - Sexually transmitted diseases, 2006 - journals.lww.com Objectives: To evaluate opportunities for earlier human immuno- deficiency virus
(HIV) diagnosis within a comprehensive public health care system. Study Design:
Retrospective review of newly diagnosed HIV-in- fected patients between ... Cited by 37 - Related articles - BL Direct - All 4 versions
- ►hem-aids.ru [PDF] RP Walensky, MC Weinstein, AD Kimmel, GR … - The American journal of medicine, 2005 - Elsevier At an undiagnosed inpatient HIV prevalence of 1% and an overall participation
rate of 33%, HIV screening increased mean quality-adjusted life expectancy by
6.13 years per 1000 inpatients, with a cost-effectiveness ratio of $35 400 ... Cited by 55 - Related articles - All 6 versions
- ►nejm.org GD Sanders, AM Bayoumi, V Sundaram, SP … - The New England Journal of Medicine (CME), 2005 - cme.nejm.org Results Given a 1 percent prevalence of unidentified HIV infection, screening
increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an
estimated cost of $194 per screened patient, for a cost-effectiveness ratio ... Cited by 225 - Related articles - Cached - All 17 versions
- ►adolescentaids.org [PDF] AD Paltiel, MC Weinstein, AD Kimmel, GR … - New England Journal of Medicine, 2005 - content.nejm.org From the Department of Epidemiology and Public Health, Yale School of Medi-
cine, New Haven, Conn. (ADP); and the Center for Risk Analysis, Department of
Health Policy and Management, Harvard School of Public Health (MCW, KAF), ... Cited by 203 - Related articles - All 17 versions
SB Lyss, BM Branson, KA Kroc, EF Couture, … - JAIDS Journal of Acquired Immune Deficiency …, 2007 - journals.lww.com Results: Of 4849 eligible patients approached for screening, 2824 (58%) accepted
and were tested; 414 (95%) of 436 provider-referred patients accepted and were
tested. Thirty-five (1.2%) screened patients and 48 (11.6%) ... Cited by 45 - Related articles - BL Direct - All 7 versions
- ►annals.org [PDF] RP Walensky, AD Paltiel - Annals of internal medicine, 2006 - Am Coll Physicians The US Food and Drug Administration (FDA) is considering ap- proval of an
over-the-counter, rapid HIV test for home use. To date, testimony presented
before the FDA has been overwhelm- ingly supportive. Advocates have argued ... Cited by 13 - Related articles - All 4 versions
DR Holtgrave - PLoS Med, 2007 - medicine.plosjournals.org Basic methods of scenario and cost-effectiveness analysis were used, from a
payer's perspective over a one-year time horizon. I found that for the same
programmatic cost of US$864,207,288, targeted counseling and testing ... Cited by 29 - Related articles - Cached - All 19 versions
- ►nih.gov RV Liddicoat, NJ Horton, R Urban, E Maier, D … - Journal of general internal medicine, 2004 - Springer BACKGROUND: Many HIV-infected persons learn about their diagnosis years after
initial infection. The extent to which missed opportunities for HIV testing
occur in medical evalu- ations prior to one's HIV diagnosis is not known. ... Cited by 67 - Related articles - BL Direct - All 8 versions
BM Branson - Annals of Internal Medicine, 2006 - Am Coll Physicians No effective treatment existed, and specific pretest counseling evolved (based
on models used with genetic testing for untreatable conditions) to ensure that
persons who sought HIV testing were aware of the uncertain meaning of a ... Cited by 8 - Related articles - BL Direct - All 3 versions
